A B Kremer
Overview
Explore the profile of A B Kremer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zujewski J, Horak I, Bol C, Woestenborghs R, Bowden C, End D, et al.
J Clin Oncol
. 2000 Feb;
18(4):927-41.
PMID: 10673536
Purpose: To determine the maximum-tolerated dose, toxicities, and pharmacokinetic profile of the farnesyl protein transferase inhibitor R115777 when administered orally bid for 5 days every 2 weeks. Patients And Methods:...
2.
Scher H, KELLY W, Zhang Z, Ouyang P, Sun M, Schwartz M, et al.
J Natl Cancer Inst
. 1999 Feb;
91(3):244-51.
PMID: 10037102
Background: With an hypothesis that post-chemotherapy changes in serum prostate-specific antigen (PSA) levels might serve as a surrogate marker for assessing prostate cancer outcome (i.e., survival), we studied the relationship...
3.
Horak I, Kremer A, Magrath I
Baillieres Clin Haematol
. 1996 Dec;
9(4):707-26.
PMID: 9138614
The NHLs are a group of neoplasms that share a common target tissue, and are characterized by a high degree of biological and clinical heterogeneity. Adult lymphomas with a high...
4.
Seidmon E, Trump D, Kreis W, Hall S, Kurman M, Ouyang S, et al.
Ann Surg Oncol
. 1995 Nov;
2(6):550-6.
PMID: 8591087
Background: Liarozole binds to the cytochrome P-450-dependent hydroxylating enzymes involved in steroid biosynthesis and retinoic acid catabolism. This phase I study investigated the clinical/endocrine toxicity profile of liarozole and determined...
5.
Fischl M, RESNICK L, Coombs R, Kremer A, Pottage Jr J, Fass R, et al.
J Acquir Immune Defic Syndr (1988)
. 1994 Feb;
7(2):139-47.
PMID: 7905523
We conducted a double-blind, randomized phase II study to evaluate the safety and activity of combination therapy with N-butyl-deoxynojirimycin (SC-48334) (an alpha-glucosidase I inhibitor) and zidovudine versus zidovudine alone. Patients...
6.
Conant M, Calabrese L, THOMPSON S, Poiesz B, Rasheed S, Hirsch R, et al.
AIDS
. 1992 Nov;
6(11):1335-9.
PMID: 1361746
Objective: To assess the efficacy and safety of thymopentin in HIV-infected patients who had not yet developed AIDS. Design: Patients were stratified into asymptomatic or symptomatic groups and randomized to...
7.
Goldstein G, Kremer A, Barnes L, Hirsch R
J Pediatr
. 1987 Dec;
111(6 Pt 2):1046-50.
PMID: 3316579
The monoclonal antibody OKT3 was previously shown to be superior to conventional high-dose steroid therapy for reversal of acute rejection of renal allografts. Furthermore, OKT3 was effective in reversing acute...
8.
Kremer A, Barnes L, Hirsch R, Goldstein G
Transplant Proc
. 1987 Apr;
19(2 Suppl 1):54-7.
PMID: 3105141
No abstract available.
9.
Hirsch R, Layton P, Barnes L, Kremer A, Goldstein G
Transplant Proc
. 1987 Apr;
19(2 Suppl 1):32-6.
PMID: 3105138
No abstract available.
10.
Kremer A, Mikita T, Beardsley G
Biochemistry
. 1987 Jan;
26(2):391-7.
PMID: 3828314
The cytotoxic analogue of thymine, 5-fluorouracil (Uf), is known to be incorporated into DNA in biological systems. This abnormal base has been synthetically incorporated into short DNA oligomers. The ionization...